LHC
VRTX icon

Little House Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Little House Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.54M Buy
9,134
+173
+2% +$76.7K 1.02% 32
2026
Q1 		$4M Buy
8,961
+22
+0.2% +$10.3K 1.03% 29
2025
Q4 		$4.05M Sell
8,939
-821
-8% -$354K 1.02% 30
2025
Q3 		$3.82M Buy
9,760
+3,930
+67% +$1.64M 0.88% 36
2025
Q2 		$2.6M Sell
5,830
-477
-8% -$220K 0.65% 44
2025
Q1 		$3.06M Buy
6,307
+1,573
+33% +$733K 0.84% 34
2024
Q4 		$1.91M Buy
4,734
+1,011
+27% +$469K 0.54% 48
2024
Q3 		$1.73M Buy
3,723
+1,033
+38% +$496K 0.5% 56
2024
Q2 		$1.26M Buy
2,690
+191
+8% +$82.9K 0.39% 58
2024
Q1 		$1.04M Buy
2,499
+179
+8% +$75.7K 0.35% 71
2023
Q4 		$944K Buy
2,320
+859
+59% +$317K 0.34% 76
2023
Q3 		$508K Buy
1,461
+42
+3% +$14.7K 0.21% 91
2023
Q2 		$499K Buy
1,419
+14
+1% +$4.72K 0.21% 90
2023
Q1 		$443K Buy
1,405
+12
+0.9% +$3.6K 0.21% 93
2022
Q4 		$402K Sell
1,393
-14
-1% -$4.27K 0.2% 90
2022
Q3 		$407K Buy
1,407
+23
+2% +$6.62K 0.22% 88
2022
Q2 		$390K Sell
1,384
-331
-19% -$88.6K 0.21% 92
2022
Q1 		$448K Buy
1,715
+108
+7% +$25.6K 0.23% 105
2021
Q4 		$353K Buy
1,607
+292
+22% +$56.8K 0.19% 113
2021
Q3 		$239K Buy
+1,315
New +$257K 0.14% 129
2021
Q1 		– Sell
-1,399
Closed -$330K – 165
2020
Q4 		$330K Buy
+1,399
New +$321K 0.24% 82

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Little House Capital's VRTX Position: Q2 2026 in Review

Little House Capital increased its Vertex Pharmaceuticals (VRTX) stake by 1.9% in Q2 2026, buying an estimated $76.7K and bringing the position to 9,134 shares worth $4.54M. The position accounts for 1.02% of the portfolio, ranked #32.

Little House Capital first reported a position in VRTX in Q4 2020 and has held it in 21 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Little House Capital held 9,134 shares of Vertex Pharmaceuticals worth $4.54M as of Q2 2026.
  • Little House Capital bought 173 Vertex Pharmaceuticals shares in Q2 2026, an estimated $76.7K.
  • Vertex Pharmaceuticals made up 1.02% of Little House Capital's portfolio in Q2 2026, its #32 holding.
  • Little House Capital first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 21 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Little House Capital's 13F filing for Q2 2026, filed 7 Aug 2026.